Shu Li

15PUBLICATIONS
17CO-AUTHORS
AutoimmunityImmunogenetics (incl. genetic immunology)Molecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 19, 2026
Unconventional role of hydroxymethylglutaryl-CoA synthase 1 in driving pathogenic TH17 cell immunity and autoimmune diseases.

|Aug 13, 2026
MARCH2/3 target FcγRI for K27-linked polyubiquitination and degradation to restrict the inflammatory response.

|Apr 24, 2026
MARCH2 mediates K27-Linked polyubiquitination of IL-2 receptor α to negatively regulate T cell proliferation.

|Apr 10, 2026
Reciprocal regulation of TNF receptor 1-mediated signaling and inflammatory damages by MARCH2 and USP22.

Hui-Fang Li, Rui Liu, Peng Ren

|Sep 09, 2025
Nuclear glycine decarboxylase suppresses STAT1-dependent MHC-I and promotes cancer immune evasion.

Rui Liu, Hui-Fang Li, Qi Jiang

|Aug 15, 2025
The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target TIM-1 to limit Zika virus infection.

Qi Zhang, Zhen-Wu Ma, Hui-Fang Li

Pageof 3

Frequent Collaborators

10 joint publications

Hong-Bing Shu

2 joint publications

Yong Xiong

2 joint publications

Zi-Lun Ruan

2 joint publications

Rui Liu